Comparing 2 hypotheses side-by-side
**Molecular Mechanism and Rationale** The fundamental mechanism underlying this therapeutic approach centers on the precise molecular orchestration of synaptic maintenance through phosphatidylserine (PS) exposure regulation. Under normal physiological conditions, PS is actively maintained on the inner leaflet of the plasma membrane through the action of ATP-dependent aminophospholipid translocases, particularly ATP11C and CDC50A. However, during synaptic stress—whether induced by oxidative dama
**SASP-Mediated Complement Cascade Amplification in Alzheimer's Disease** **Overview: Senescence, Inflammation, and Synaptic Loss** Cellular senescence—a state of irreversible growth arrest accompanied by a pro-inflammatory secretome—accumulates dramatically with age and in Alzheimer's disease. Senescent astrocytes and microglia secrete the senescence-associated secretory phenotype (SASP), a cocktail of cytokines, chemokines, proteases, and critically, complement cascade initiators including C
| Dimension | Synaptic Phosphatidylserine Ma | SASP-Mediated Complement Casca |
|---|---|---|
| Mechanistic | 0.550 | 0.750 |
| Evidence | 0.450 | 0.700 |
| Novelty | 0.750 | 0.850 |
| Feasibility | 0.500 | 0.750 |
| Impact | 0.600 | 0.800 |
| Druggability | 0.550 | 0.850 |
| Safety | 0.500 | 0.600 |
| Competition | 0.800 | 0.800 |
| Data | 0.450 | 0.750 |
| Reproducible | 0.500 | 0.700 |
4 rounds · quality: 0.61
# Novel Therapeutic Hypotheses for Synaptic Pruning in Early Alzheimer's Disease ## Hypothesis 1: Complement C1q Mimetic Decoy Therapy **Description:** Engineer synthetic C1q mimetics that bind to sy...
# Novel Therapeutic Hypotheses for Synaptic Pruning in Early Alzheimer's Disease ## Hypothesis 1: Complement C1q Mimetic Decoy Therapy **Description:** Engineer synthetic C1q mimetics that bind to sy...
# Critical Evaluation of Synaptic Pruning Therapeutic Hypotheses ## Hypothesis 1: Complement C1q Mimetic Decoy Therapy **Specific Weaknesses:** - **Selectivity Problem:** C1q has essential physiolog...
# Critical Evaluation of Synaptic Pruning Therapeutic Hypotheses ## Hypothesis 1: Complement C1q Mimetic Decoy Therapy **Specific Weaknesses:** - **Selectivity Problem:** C1q has essential physiolog...
4 rounds · quality: 0.60
# Novel Therapeutic Hypotheses for Age-Related Neurodegeneration ## 1. Senescence-Activated NAD+ Depletion Rescue **Description:** Senescent glial cells upregulate CD38 NADase, creating local NAD+ de...
# Novel Therapeutic Hypotheses for Age-Related Neurodegeneration ## 1. Senescence-Activated NAD+ Depletion Rescue **Description:** Senescent glial cells upregulate CD38 NADase, creating local NAD+ de...
# Critical Evaluation of Age-Related Neurodegeneration Hypotheses ## 1. Senescence-Activated NAD+ Depletion Rescue ### Specific Weaknesses: - **Spatial specificity unclear**: No evidence that CD38 u...
# Critical Evaluation of Age-Related Neurodegeneration Hypotheses ## 1. Senescence-Activated NAD+ Depletion Rescue ### Specific Weaknesses: - **Spatial specificity unclear**: No evidence that CD38 u...
No shared papers found across 54 total unique citations. These hypotheses draw from independent evidence bases.